These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11393348)

  • 21. Moxifloxacin Bayer.
    Barrett JF
    Curr Opin Investig Drugs; 2000 Sep; 1(1):45-51. PubMed ID: 11249594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.
    Pauwels RA; Buist AS; Calverley PM; Jenkins CR; Hurd SS;
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1256-76. PubMed ID: 11316667
    [No Abstract]   [Full Text] [Related]  

  • 23. Breathing lessons: the costs of COPD.
    Smith MD; McGhan WF
    Bus Health; 1996 Oct; 14(10):79-80, 82. PubMed ID: 10161493
    [No Abstract]   [Full Text] [Related]  

  • 24. [Novel antibiotics active against Gram-positive bacteria].
    Garcia Sánchez JE; Fresnadillo Martínez MJ
    Rev Esp Quimioter; 2000 Dec; 13(4):344-51. PubMed ID: 11498700
    [No Abstract]   [Full Text] [Related]  

  • 25. [Investigation of moxifloxacin, a new antimicrobial of the fluoroquinolone group in Russia].
    Iakovlev VS; Iakovlev VP
    Antibiot Khimioter; 2007; 52(6):28-35. PubMed ID: 18476472
    [No Abstract]   [Full Text] [Related]  

  • 26. [Moxifloxacin clinical and microbiological efficacy in therapy of infectious endocarditis].
    Beloborodova NV; Popov DA; Bachinskaia EN; Sedrakian AR; Vostrikova TIu
    Antibiot Khimioter; 2006; 51(9-10):33-9. PubMed ID: 18030789
    [No Abstract]   [Full Text] [Related]  

  • 27. Moxifloxacin-dependent Torsades de Pointes.
    Tiryakioğlu SK; Tiryakioğlu O; Aktürk F; Mehmetoğlu E; Kumbay E
    Anadolu Kardiyol Derg; 2011 Sep; 11(6):560-2. PubMed ID: 21827995
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of Staphylococcus aureus endocarditis using moxifloxacin.
    Berrington AW; Koerner RJ; Perry JD; Bain HH; Gould FK
    Int J Med Microbiol; 2001 Aug; 291(3):237-9. PubMed ID: 11554565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moxifloxacin: new indication. Inadequate restriction of indications in ENT and respiratory infections.
    Prescrire Int; 2009 Oct; 18(103):206. PubMed ID: 19882787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moxifloxacin in acute exacerbations of chronic bronchitis: clinical evaluation and assessment by patients.
    Lorenz J; Busch W; Thate-Waschke IM;
    J Int Med Res; 2001; 29(2):61-73. PubMed ID: 11393350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moxifloxacin: new indication. Do not use in gynaecological infections or other conditions.
    Prescrire Int; 2009 Oct; 18(103):207. PubMed ID: 19882788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A light at the end of the tunnel of inflammation in obstructive airway diseases?
    Gibson PG
    Chest; 2008 Sep; 134(3):475-476. PubMed ID: 18779188
    [No Abstract]   [Full Text] [Related]  

  • 33. Avelox. Respiratory antibiotic now in i.v. form.
    Nursing; 2002 Mar; 32(3):26. PubMed ID: 11902040
    [No Abstract]   [Full Text] [Related]  

  • 34. "There's no such thing as a free meal".
    Rosenberg R
    Conn Med; 2002 Jun; 66(6):366. PubMed ID: 12143121
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis.
    Wilson R; Macklin-Doherty A
    Expert Rev Respir Med; 2012 Nov; 6(5):481-92. PubMed ID: 23113693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study.
    Miravitlles M; Anzueto A; Ewig S; Legnani D; Stauch K
    Ther Adv Respir Dis; 2009 Dec; 3(6):267-77. PubMed ID: 19880426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy study of acute exacerbated chronic bronchitis. Quinolone rapidly improves cough and chest pain. BRONCHIMOX Study Group].
    Lorenz J; Busch W; Thate-Waschke IM
    MMW Fortschr Med; 2000 Jun; 142(22):35. PubMed ID: 10870381
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical experience in Germany of treating community-acquired respiratory infections with the new 8-methoxyfluoroquinolone, moxifloxacin.
    Landen H; Möller M; Tillotson GS; Kubin R; Höffken G
    J Int Med Res; 2001; 29(2):51-60. PubMed ID: 11393349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [One year moxifloxacin. Still effective in the respiratory tract].
    MMW Fortschr Med; 2001 Feb; 143(7):60. PubMed ID: 11268757
    [No Abstract]   [Full Text] [Related]  

  • 40. Bactericidal activity of moxifloxacin against pneumococci.
    Levy D; Berche P
    Clin Microbiol Infect; 2001 Jan; 7(1):47-8. PubMed ID: 11284948
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.